The former patient, Gail Seiler, aired the allegations during a roundtable discussion hosted by Republican U.S. Sen. Ron ...

The biopharmaceutical company said it now expects total revenue growth of 15% to 25% for the year, compared with a previous outlook for up to 10% growth.

Helen Branswell covered issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. In April 2020, people around the globe were struggling to ...

A study found COVID-19 vaccines generated returns of up to $809 for every dollar invested during their first year of rollout.

An Illinois man pleaded guilty to running a $227 million fraud scheme that billed Medicare for COVID-19 tests that patients ...

Canada becomes the first country to authorize both Moderna’s mRNA seasonal influenza vaccine, mFLUSIVA ®, and combination influenza and COVID-19 vaccine, mCOFLU ® CAMBRIDGE, M ...

This year, the agency predicts that COVID-19, the flu and RSV could cause a similar number of cases and hospitalizations. ...

Our World in Data also publishes data on COVID-19 fatality rates, in which low-income countries also experience worse ...

From Stratus to Cicada, several variants are on the radar as COVID-19 activity rises, impacting how the virus spreads, its severity, and how it interacts with the immune system. As we near infectious ...

SIRVA was rare after COVID-19 and flu shots, but COVID-19 vaccination had about 7 more cases per 100,000 doses in a study of 1.8 million.

Alberta doesn't have a shortage of COVID-19 vaccine, despite pharmacists' concerns, according to Primary and Preventative ...

An Ontario Superior Court judge granted the class action certification last week for a lawsuit alleging that gross negligence ...